Stock detail
Ptc Therapeutics (PTCT) stock price, chart, and key data
View Ptc Therapeutics stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Ptc Therapeutics
PTCT · XNAS
$66.41
-1.40%
-$0.94
Key metrics
52-week range
$4.75 - $2.00
Close price
$67.35
Market cap
$5.6B
P/E ratio
-280.61
Beta
0.72
About the company
Ptc Therapeutics Inc
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$101
8
Buy
/ 10
Recent calls
09/02/2026
Wells Fargo
Benjamin Burnett
Buy · Price target $109
08/30/2026
TD Cowen
Joseph Thome
Buy · Price target $90.00
08/13/2026
Barclays
Eliana Merle
Buy · Price target $122
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Donald J Trump republican · Executive self |
| 614/921/1,229 |
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app